Beauty kit and beauty method using the same

The beauty kit with a foam cleanser and cosmetic composition addresses the slow effects of existing preparations by using a specific formulation and application method to rapidly improve skin brightness and reduce melanin levels.

JP7814984B2Active Publication Date: 2026-02-17NOEVIR CO LTD
View PDF 10 Cites 0 Cited by

Patent Information

Application Number
JP2022035967
Authority / Receiving Office
JP · JP
Patent Type
Patents
Current Assignee / Owner
Filing Date
2022-03-09
Publication Date
2026-02-17
Estimated Expiration
2042-03-09

AI Technical Summary

Technical Problem

Existing external skin preparations and whitening agents take a long time to show noticeable effects.

Method used

A beauty kit comprising a foam cleanser with a higher fatty acid salt, higher alcohol, nonionic surfactant with an HLB value of 12 or more, and carbon dioxide propellant, and a cosmetic containing L-ascorbic acid and/or hydroquinone derivatives, applied in a specific method to enhance skin brightness and reduce melanin levels.

Benefits of technology

The beauty kit effectively reduces blemishes and melanin levels, increases skin brightness, and reduces redness in a short period.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 0007814984000005
    Figure 0007814984000005
  • Figure 0007814984000006
    Figure 0007814984000006
  • Figure 0007814984000007
    Figure 0007814984000007
Patent Text Reader

Abstract

To provide a beauty kit that delivers noticeable effects quickly and a beauty method using the same.SOLUTION: A beauty kit includes: a foaming cleanser that contains a higher fatty acid salt, a higher alcohol and a nonionic surfactant with an HLB value of 12 or more, and also contains carbon dioxide as a propellant; and cosmetics that contain two or more selected from L-ascorbic acid and salts thereof or derivatives thereof and hydroquinone or derivatives thereof as active ingredients. A beauty method uses the kit. When applying the foaming cleanser, massage should be preferably performed for at least 20 seconds.SELECTED DRAWING: Figure 1
Need to check novelty before this filing date? Find Prior Art

Description

[Technical Field]

[0001] The present invention relates to a beauty kit and a beauty method using the same. [Background technology]

[0002] Factors that contribute to the worsening of skin conditions such as wrinkles, sagging skin, pigmentation, changes in skin tone, loss of skin elasticity, and disturbances in skin surface morphology include, for example, wrinkles and sagging caused by a decline in the function of dermal fibroblasts due to dryness and aging, the accompanying decrease and degeneration of dermal matrix such as collagen and elastin, and oxidative damage caused by external stress such as ultraviolet rays. Furthermore, while some aspects of pigmentation and changes in skin tone, including darkening of the skin, are unknown, they are thought to be caused by the production of melanin pigment due to hormonal abnormalities and stimulation by ultraviolet rays from sunlight, and among these, age spots and freckles are thought to be caused by abnormal deposition of melanin pigment.

[0003] Various methods have been investigated to solve these problems, including a topical skin preparation containing pullulan and tranexamic acid or a salt thereof (Patent Document 1), a whitening agent containing ethyl chlorogenic acid as an active ingredient (Patent Document 2), and a topical skin preparation containing tranexamic acid, a urethane resin, and gellan gum (Patent Document 3). [Prior art documents] [Patent documents]

[0004] [Patent Document 1] Patent Publication No. 2021-091643 [Patent Document 2] Japanese Patent Application Laid-Open No. 2014-227393 [Patent Document 3] Japanese Patent Publication No. 2021-167284 Summary of the Invention [Problem to be solved by the invention]

[0005] However, there is a problem that it takes time for the above-mentioned external skin preparations and whitening agents to have a noticeable effect when used alone. The present invention has been made in view of the above circumstances, and aims to provide a beauty kit that allows users to realize the effects in a short period of time, and a beauty method using the same. [Means for solving the problem]

[0006] (1) The beauty kit comprises a foam cleanser containing a higher fatty acid salt, a higher alcohol, and a nonionic surfactant with an HLB value of 12 or more, and containing carbon dioxide as a propellant, and a cosmetic containing two or more active ingredients selected from L-ascorbic acid and its salts or derivatives, and hydroquinone or its derivatives. (2) A beauty method characterized by applying to the skin a foam cleanser containing a higher fatty acid salt, a higher alcohol, and a nonionic surfactant with an HLB value of 12 or more, and carbon dioxide as a propellant, and then applying to the skin a cosmetic composition containing two or more active ingredients selected from L-ascorbic acid and its salts or derivatives, and hydroquinone or its derivatives. (3) 3. The beauty method according to claim 2 (excluding medical use), characterized in that the foam cleanser is massaged into the skin for 20 seconds or more when applied to the skin. [Effects of the Invention]

[0007] The beauty kit of the present invention exhibits excellent effects of reducing blemishes and melanin levels, increasing skin brightness, and reducing redness in a short period of time. [Brief explanation of the drawings]

[0008] [Figure 1] FIG. 1 shows the change in the amount of stains before and after Usage Test 1.

[0009] [Figure 2] FIG. 2 is a graph showing the change in the amount of melanin before and after Usage Test 1.

[0010] [Figure 3] FIG. 3 is a graph showing the change in L* value before and after Usage Test 2.

[0011] [Figure 4] FIG. 4 is a diagram showing the change in a* value before and after Usage Test 2. DETAILED DESCRIPTION OF THE INVENTION

[0012] Hereinafter, an embodiment of the present invention will be described.

[0013] The foam cleanser of the present invention can be used for both cosmetics and quasi-drugs.

[0014] The higher fatty acids constituting the higher fatty acid salt used in the foam cleanser of the present invention may be either saturated or unsaturated, and may have a straight or branched chain. The number of carbon atoms constituting the higher fatty acid is preferably 8 to 24, and particularly preferably 10 to 24. These fatty acids may be used alone or in combination of two or more. Examples of straight-chain saturated fatty acids include lauric acid, myristic acid, palmitic acid, stearic acid, arachidic acid, behenic acid, lignoceric acid, oleic acid, coconut oil fatty acid, reduced coconut oil fatty acid, and palm kernel fatty acid. Examples of branched-chain fatty acids include isomyristic acid, isopalmitic acid, and isostearic acid. Among these fatty acids, it is preferable to use one or more selected from stearic acid, arachidic acid, behenic acid, and lignoceric acid in terms of massage effect, and it is most preferable to use behenic acid. Examples of alkaline agents that form salts with these higher fatty acids include alkali metal salts such as sodium and potassium, ammonium salts, alkanolamine salts such as monoethanolamine, diethanolamine, triethanolamine, 2-amino-2-methylpropanol, and 2-amino-2-methylpropanediol, and basic amino acid salts such as lysine and arginine. Of these, 2-amino-2-methylpropanol and arginine are particularly preferred.

[0015] Furthermore, these higher fatty acid salts do not necessarily need to be blended in the cleanser as fatty acid salts, and the above higher fatty acids and alkaline agents may be added separately to form fatty acid salts.

[0016] The amount of higher fatty acid and its salt is preferably 1 to 10% by mass, more preferably 1 to 8% by mass, of the total amount of the foam cleanser as higher fatty acid. If the amount is less than 1% by mass, sufficient cleansing power may not be exerted. If the amount is more than 10% by mass, the viscosity of the foam cleanser increases, and it may not be possible to discharge it.

[0017] The higher alcohol used in the foam cleanser of the present invention is a higher alcohol having 8 to 30 carbon atoms. Such higher alcohols are linear or branched, saturated or unsaturated hydrocarbon monohydric alcohols, and may be used alone or in combination of two or more. Specific examples include caprylyl alcohol, capryl alcohol, lauryl alcohol, myristyl alcohol, cetyl alcohol, hexyldecanol, stearyl alcohol, isostearyl alcohol, arachidyl alcohol, behenyl alcohol, lignoceryl alcohol, oleyl alcohol, carnaubyl alcohol, and ceryl alcohol. Among these higher alcohols, one or more selected from stearyl alcohol, arachidyl alcohol, behenyl alcohol, and lignoceryl alcohol are preferably used, with behenyl alcohol being most preferred from the viewpoint of massage properties.

[0018] The amount of higher alcohol is preferably 1 to 10% by mass, more preferably 1 to 8% by mass, based on the total amount of the foam cleanser. If the amount is less than 1% by mass, the foam cleanser may not exhibit sufficient massaging properties. If the amount is more than 10% by mass, the viscosity of the foam cleanser may increase, making it impossible to discharge.

[0019] The nonionic surfactant having an HLB value of 12 or more used in the foam cleanser of the present invention may be any surfactant used in ordinary cleansers, such as polyoxyethylene sorbitan fatty acid esters, polyglycerin fatty acid esters, polyoxyethylene fatty acid esters, polyoxyethylene alkyl ethers, and polyoxyethylene hydrogenated castor oil.

[0020] Examples of polyoxyethylene sorbitan fatty acid esters include POE (80) sorbitan monolaurate (HLB value 19.0), POE (20) sorbitan monolaurate (HLB value 16.9), POE (6) sorbitan monolaurate (HLB value 15.5), POE (20) sorbitan monopalmitate (HLB value 15.6), and POE (20) sorbitan monostearate (HLB value 14.9). Examples of polyglycerin fatty acid esters include hexaglyceryl monolaurate (HLB value 14.5) and decaglyceryl monolaurate (HLB value 15.5). Examples of polyoxyethylene fatty acid esters include POE (10) monolaurate (HLB value 12.5), POE (25) monostearate (HLB value 15.0), and POE (240) monostearate (HLB value 17.5). Examples of polyoxyethylene alkyl ethers include POE (9) lauryl ether (HLB value 14.5), POE (10) cetyl ether (HLB value 13.5), POE (20) phytosterol ether (HLB value 15.5), POE (30) phytosterol ether (HLB value 18.0), POE (25) phytostanol (HLB value 14.5), etc. Examples of polyoxyethylene hydrogenated castor oils include POE (40) hydrogenated castor oil (HLB value 12.5), POE (60) hydrogenated castor oil (HLB value 14.0), etc.

[0021] Here, the HLB value (Hydphile-Lipophile Balance) in the present invention is an index showing the balance of hydrophilicity and lipophilicity, and is calculated by Oda and Teramura et al. using the following formula (1): HLB value = inorganic value (IV) / organic value (OV) × 10 (Equation 1) (See Yoshio Koda, "Organic Conceptual Diagram - Fundamentals and Applications", pp. 11-17, Sankyo Publishing, 1984)

[0022] The amount of nonionic surfactants with an HLB value of 12 or more is preferably 1 to 10% by mass, more preferably 1 to 8% by mass, based on the total amount of the foam cleanser. If the amount is less than 1% by mass, rinsing performance may be poor. If the amount is more than 10% by mass, the rinsing effect may not be improved, which is inefficient.

[0023] The propellant used in the foam cleanser of the present invention contains carbon dioxide as an essential component.

[0024] From the viewpoint of cosmetic effects, it is preferable that the amount of carbon dioxide is 1 to 100% by mass of the total amount of the propellant.

[0025] Carbon dioxide may be used alone as the propellant, or may be mixed with other propellants, such as nitrogen, propane, normal butane, isobutane, and mixtures thereof such as liquefied petroleum gas (LPG), dimethyl ether, isopentane, and other liquefied gases, within the range that does not impair the effects of the present invention.

[0026] The amount of propellant filled in the foam cleanser of the present invention is preferably 0.5% by mass or more, more preferably 1% by mass or more, and preferably 10% by mass or less, more preferably 8% by mass or less, when the total amount of the foam cleanser concentrate and propellant is taken as 100% by mass, from the viewpoints of improving the foam quality immediately after ejection, improving the re-foaming ability of the foam cleanser, and obtaining an appropriate spray speed.

[0027] The foam cleanser of the present invention is filled into an aerosol container for use. Examples of such aerosol containers include known pressure-resistant containers made of metal or the like, and double-structure containers in which an inner bag is housed inside a pressure-resistant container. In the case of double-structure containers, it is preferred that the foam cleanser be filled into the inner bag, and a propellant be filled between the pressure-resistant container and the inner bag.

[0028] The method for preparing the foam cleanser of the present invention is not particularly limited. For example, it can be prepared by filling a pressure-resistant container that constitutes an aerosol container with the foam cleanser, attaching a valve, and then filling the propellant through the valve.

[0029] The foam cleanser of the present invention may contain bases other than the above-mentioned essential ingredients as long as the effects of the present invention are not impaired. Specific examples of such bases include oils, surfactants other than those mentioned above, thickeners, preservatives, fragrances, moisturizers, antioxidants, anti-inflammatory agents, and antibacterial agents.

[0030] The L-ascorbic acid and its salts or derivatives thereof used in the cosmetic composition of the present invention containing two or more active ingredients selected from L-ascorbic acid and its salts or derivatives, and hydroquinone or its derivatives are not particularly limited as long as they can be normally incorporated into cosmetic compositions. Specific examples of L-ascorbic acid and ascorbic acid derivatives include L-ascorbic acid monoesters such as L-ascorbic acid glucoside, L-ascorbic acid-2-phosphate, L-ascorbic acid-3-phosphate, L-ascorbic acid-6-phosphate, L-ascorbic acid-2-polyphosphate, and L-ascorbic acid-2-sulfate; L-ascorbic acid monoalkyl esters such as L-ascorbic acid-2-palmitate, L-ascorbic acid-6-palmitate, L-ascorbic acid-2-stearate, and L-ascorbic acid-6-stearate; L-ascorbic acid monoalkyl esters such as L-ascorbic acid glucoside, L-ascorbic acid-2-phosphate, L-ascorbic acid-3-phosphate, L-ascorbic acid-6-phosphate, L-ascorbic acid-2-polyphosphate, and L-ascorbic acid-2-sulfate; L-ascorbic acid monoalkyl esters such as L-ascorbic acid-2-palmitate, L-ascorbic acid-6-palmitate, L-ascorbic acid-2-stearate, and L-ascorbic acid-6-stearate; L-ascorbic acid dialkyl esters such as L-ascorbic acid 2,6-dibutyl ester and L-ascorbic acid 2,6-dipalmitate, L-ascorbic acid trialkyl esters such as L-ascorbic acid tristearate, L-ascorbic acid trioleate, and L-ascorbic acid tripalmitate, L-ascorbic acid triesters such as L-ascorbic acid triphosphate, L-ascorbic acid tetraalkyl esters such as L-ascorbyl tetraisopalmitate, dl-α-tocopherol 2-L-ascorbic acid phosphate diester, and salts of ascorbic acid and ascorbic acid derivatives include sodium salts, potassium salts, magnesium salts, calcium salts, barium salts, ammonium salts, monoethanolamine salts, diethanolamine salts, triethanolamine salts, monoisopropanolamine salts, and triisopropanolamine salts. Among these, ascorbic acid 2-glucoside and magnesium ascorbyl phosphate are preferred. Commercially available products include AA2G (Hayashibara Co., Ltd.), C-mate (BASF Japan Ltd.), and NIKKOLVC-PMG (Nikko Chemicals Co., Ltd.).

[0031] As hydroquinone or a derivative thereof, it is particularly preferable to use arbutin, which is a hydroquinone glycoside. Commercially available products include ARBUTIN (HYINDAI BIOLAND Co., Ltd.), ARBUTIN (Nippon Fine Chemical Co., Ltd.), ARBUTIN (SK Bioland Co., Ltd.), and ARBUTIN I (Yusai Chemical Industry Co., Ltd.).

[0032] The blending amount of two or more selected from L-ascorbic acid and its salts or derivatives, and hydroquinone and its derivatives is preferably 1 to 10% by mass of the total amount of the cosmetic. Blending less than 1% by mass may not achieve the cosmetic effects of the present invention. Blending more than 10% by mass may not achieve further improvement in the cosmetic effects, and is inefficient.

[0033] The cosmetic composition of the present invention preferably contains an anti-inflammatory agent, such as glycyrrhizinic acid, azulene, salicylic acid, allantoin, derivatives thereof, and salts thereof.

[0034] Glycyrrhizic acid, its derivatives, and salts thereof are not particularly limited as long as they can be incorporated into cosmetics, but specific examples include glycyrrhizic acid, dipotassium glycyrrhizinate, monoammonium glycyrrhizinate, etc. Among these, it is preferable to use dipotassium glycyrrhizinate. Commercially available products include glycyrrhizic acid, dipotassium glycyrrhizinate, monoammonium glycyrrhizinate (all from Alps Pharmaceutical Co., Ltd.), dipotassium glycyrrhizinate, monoammonium glycyrrhizinate (all from Maruzen Pharmaceutical Co., Ltd.), dipotassium glycyrrhizinate "Koki," and monoammonium glycyrrhizinate "Koki" (all from Kouki Co., Ltd.).

[0035] When glycyrrhizinic acid, its derivatives, and salts thereof are blended, the blending amount is preferably 0.0001% by mass or more of the total amount of the cosmetic, and is preferably 2% by mass or less, more preferably 0.8% by mass or less for rinse-off products and 0.5% by mass or less for leave-in products.

[0036] Glycyrrhetinic acid, its derivatives, and salts thereof are not particularly limited as long as they can be incorporated into cosmetics, but specific examples include glycyrrhetinic acid, stearyl glycyrrhetinate, glycerin glycyrrhetinate, etc. Among these, it is preferable to use glycyrrhetinic acid and stearyl glycyrrhetinate. Commercially available products include β-glycyrrhetinic acid, stearyl glycyrrhetinate (both from Alps Pharmaceutical Co., Ltd.), glycyrrhetinic acid, C.O. Glycinol (registered trademark) (both from Maruzen Pharmaceutical Co., Ltd.), Agritinone, Agritinone Stearyl (both from Tokiwa Phytochemical Research Institute Co., Ltd.), Glycyrrhetinic Acid "Koki", and Glycyrrhetinate Stearyl "Koki" (both from Kouki Co., Ltd.).

[0037] When glycyrrhetinic acid, its derivatives, and salts thereof are blended, the blending amount is preferably 0.0001% by mass or more of the total amount of the cosmetic, and is preferably 2% by mass or less, more preferably 0.8% by mass or less for rinse-off products and 0.5% by mass or less for leave-in products.

[0038] Azulene, its derivatives, and salts thereof are not particularly limited as long as they can be incorporated into cosmetics, but specific examples include azulene, guaiazulene, ethyl guaiazulene sulfonate, sodium guaiazulene sulfonate, chamazulene, etc. Among these, sodium guaiazulene sulfonate is preferably used. Commercially available products include guaiazulene and water-soluble azulene (both from Konan Kako Co., Ltd.).

[0039] When azulene, its derivatives, and salts thereof are blended, the blending amount is preferably 0.0001% by mass or more, and more preferably 1% by mass or less, and more preferably 0.1% by mass or less, based on the total amount of the cosmetic.

[0040] Salicylic acid, its derivatives, and their salts are not particularly limited as long as they can be incorporated into cosmetics, but specific examples include salicylic acid, methyl salicylate, glycol salicylate, sodium salicylate, ethylhexyl salicylate, etc. Among these, ethylhexyl salicylate and sodium salicylate are preferred. Commercially available products include SALICYLIC ACID (Solvay), methyl salicylate (API Corporation), sodium salicylate (Yoshitomi Fine Chemical Co., Ltd.), Escarol Salicylate 587 (Ashland Japan Co., Ltd.), and Parsol EHS (DSM Corporation).

[0041] When salicylic acid, its derivatives, and salts thereof are blended, the blending amount is preferably 0.0001% by mass or more, and more preferably 1% by mass or less, and more preferably 0.2% by mass or less, based on the total amount of the cosmetic.

[0042] Allantoin, its derivatives, and salts thereof are not particularly limited as long as they can be incorporated into cosmetics, but specific examples include allantoin, allantoin chlorhydroxyaluminum, allantoin dihydroxyaluminum, etc. Among these, allantoin is preferably used. Commercially available products include Allantoin (Ashland Japan Co., Ltd.), Allantoin, ALCA (both Kawaken Fine Chemicals Co., Ltd.), RonaCare (registered trademark) Allantoin (Meeck KgaA), etc.

[0043] When allantoin, its derivatives, and salts thereof are blended, the blending amount is preferably 0.0001% by mass or more of the total amount of the cosmetic, and is preferably 1% by mass or less, more preferably 0.5% by mass or less for rinse-off products and 0.3% by mass or less for leave-in products.

[0044] The cosmetic of the present invention may contain any component that can be incorporated into a cosmetic within the scope that does not impair the cosmetic effect of the present invention. Specific examples of such components include oils, surfactants, thickeners, preservatives, fragrances, moisturizers, antioxidants, antibacterial agents, etc.

[0045] The form of the cosmetic of the present invention is not particularly limited, and may be in the form of oil, gel, gel, solid, or the like.

[0046] The cosmetic of the present invention can be prepared by a conventional method.

[0047] The beauty kit of the present invention comprises a foam cleanser containing a higher fatty acid salt, a higher alcohol, and a nonionic surfactant with an HLB value of 12 or more, and containing carbon dioxide as a propellant, and a cosmetic composition containing two or more active ingredients selected from L-ascorbic acid and its salts or derivatives, and hydroquinone or its derivatives.

[0048] The cosmetic method of the present invention is characterized by applying to the skin a foam cleanser containing a higher fatty acid salt, a higher alcohol, and a nonionic surfactant with an HLB value of 12 or more, and containing carbon dioxide as a propellant, followed by applying to the skin a cosmetic composition containing two or more active ingredients selected from L-ascorbic acid and its salts or derivatives, and hydroquinone or its derivatives.

[0049] The cosmetic method of the present invention involves applying to the skin a foam cleanser containing a higher fatty acid salt, a higher alcohol, and a nonionic surfactant with an HLB value of 12 or more, and containing carbon dioxide as a propellant, and rinsing it off, followed by applying to the skin a cosmetic composition containing two or more active ingredients selected from L-ascorbic acid and its salts or derivatives, and hydroquinone or its derivatives.

[0050] The beauty treatment method of the present invention involves applying to the skin a foam cleanser containing a higher fatty acid salt, a higher alcohol, and a nonionic surfactant with an HLB value of 12 or more and containing carbon dioxide as a propellant, followed by application of a cosmetic product containing two or more active ingredients selected from L-ascorbic acid and its salts or derivatives, and hydroquinone or its derivatives. The cosmetic product may be applied to the skin immediately after applying the cleanser, or the cosmetic product may be applied to the skin immediately after applying the cleanser, or the cosmetic product may be applied to the skin after applying a foam cleanser containing a higher fatty acid salt, a higher alcohol, and a nonionic surfactant with an HLB value of 12 or more and containing carbon dioxide as a propellant, followed by application of an illuminating serum, lotion, etc., followed by application of a cosmetic product containing two or more active ingredients selected from L-ascorbic acid and its salts or derivatives, and hydroquinone or its derivatives.

[0051] In the beauty treatment method of the present invention, the beauty effect is further enhanced if the foam cleanser is applied to the skin and massaged for 20 seconds or more. The massage time is sufficient as long as it is 20 seconds or more, and although there is no particular upper limit, it is preferably 10 minutes or less, and more preferably 1 minute or less.

[0052] The massage can be given by the person themselves or by someone else.

[0053] The method of massage is not particularly limited, but it is preferable to massage gently in a circular motion with your fingertips. Note that the massage of the present invention does not include medical procedures.

[0054] The beauty kit of the present invention and the beauty method using the same have excellent whitening effects. [Example]

[0055] Examples of the present invention will be described below. These examples are merely examples of the present invention and are not intended to limit the scope of the present invention. The blend amounts are expressed in mass % unless otherwise specified.

[0056] Table 1 shows an example of a formulation for the foam cleanser of the present invention.

[0057] [Table 1]

[0058] Table 2 shows examples of formulations of the cosmetic compositions of the present invention.

[0059] [Table 2]

[0060] A usage test using the beauty kit of the present invention will be described.

[0061] Usage test 1 (spots, melanin amount) (subject) The subjects were four healthy men and women aged 27 to 41 years (mean age 32.5 years). (Method and period of use) The use test was conducted twice a day for two consecutive weeks. The subjects washed their faces using the foam cleanser shown in Table 1 on one half of their face and Noevir 99 Plus Cleansing Foam (Gerntol) on the other half. When washing their faces, the subjects took an appropriate amount (half the size of a ping-pong ball) of the foam cleanser shown in Table 1 in their hands without wet hands or face, spread the foam over half of their face, and gently massaged it in a circular motion with their fingertips (for about 30 seconds), then rinsed thoroughly with water or lukewarm water. After that, they applied their usual lotion to their entire face, followed by an appropriate amount of the cosmetic product shown in Table 2. (Measurement method) Before the start of the test and after two weeks, the skin was measured for age spots and melanin levels using a VISIA Evo (Canfield Scientific). Before the test, the subjects were cleansed and washed, and then allowed to acclimate for 15 minutes in a room conditioned to a temperature of 20-22°C and humidity of 45-55% to prepare the initial conditions for the measurement. (Evaluation method) The amount of dark spots and melanin measured after two weeks was calculated based on the amount of dark spots and melanin before the start of the test set at 100. The results are shown in Table 3 and Figures 1 and 2.

[0062] [Table 3]

[0063] As shown in Table 3 and Figures 1 and 2, the group using the beauty kit of the present invention had a significant reduction in both spots and melanin levels compared to the group not using the kit, demonstrating a high beauty effect.

[0064] Usage test 2 (skin color change) (subject) The subjects were two healthy males aged 27 to 41 years (mean age 32.5 years). (Method and period of use) The usage test was conducted twice a day for two consecutive weeks. The subjects washed their faces using the foam cleanser shown in Table 1 on one forearm and Noevir 99 Plus Cleansing Foam (Gerntol) on the other forearm. When washing their faces, the subjects took an appropriate amount (the size of a ping-pong ball) of the foam cleanser shown in Table 1 in their hands without wet hands or face, spread the foam on their forearms, and gently massaged in circular motions with their fingertips (for about 30 seconds), then rinsed thoroughly with water or lukewarm water. After that, they applied their usual lotion to both arms, followed by an appropriate amount of the cosmetic product shown in Table 2. (Measurement method) Before the start of the test and after two weeks, the skin was measured for brightness (L) using a spectrophotometer CM-700d (Konica Minolta Japan, Inc.). * ), redness (a * Before the measurement, the specimens were washed and allowed to acclimate for 15 minutes in a room adjusted to a temperature of 20-22°C and a humidity of 45-55% to prepare the initial conditions, and then the measurement was carried out. (Evaluation method) Brightness (L * ), redness (a * The results are shown in Table 4 and Figures 3 and 4.

[0065] [Table 4]

[0066] As shown in Table 4 and Figures 3 and 4, the group using the beauty kit of the present invention had a significantly higher L * The value increased significantly, and the a * The values ​​were significantly reduced, demonstrating a high cosmetic effect.

Claims

[Claim 1] A beauty method (excluding medical procedures) comprising applying to the skin a foam cleanser containing behenic acid, 2-amino-2-methylpropanol, behenyl alcohol, and PEG-25 phytostanol, and containing carbon dioxide as a propellant, followed by applying to the skin a cosmetic composition containing two or more active ingredients selected from L-ascorbic acid and its salts or derivatives, and hydroquinone or its derivatives, wherein the skin is massaged for 20 seconds or more when the foam cleanser is applied to the skin.

Citation Information

Patent Citations

  • Making-up

    JP1998087431A

  • Foamable aerosol composition

    JP2003252725A

  • Foam for cleansing and aqueous cleansing agent for forming the foam

    JP2008303183A

  • Skin external preparation in aerosol form

    JP2009191042A

  • Skin external preparation

    JP2011184321A